✦ LIBER ✦

Front-line treatment of advanced non-small cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

✍ Scribed by Georgoulias, V; Kourousis, Ch; Androulakis, N; Kakolyris, S; Dimopoulos, MA; Papadakis, E; Bouros, D; Apostolopoulou, F; Papadimitriou, Ch; Agelidou, A; Tzianni, V; Apostolaki, F; Hatzakis, K; Kalbakis, K; Kotsakis, A; Sarra, E; Vardakis, N; Vlachonicolis, J

Book ID: 118575462
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 120 KB
Volume: 21
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(98)90063-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel versus docetaxel plus gemcitab

Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial

✍ Georgoulias, Vassilis; Androulakis, Nikolaos; Kotsakis, Athanasios; Hatzidaki, D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Front-line treatment of advanced non-sma

Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: A multicentre phase II study

✍ Ziotopoulos, Panagiotis; Androulakis, Nikolaos; Mylonaki, Efthimia; Chandrinos, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Results of a phase II multicenter trial

Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Neubauer, Marcus A.; Garfield, David H.; Kuerfler, Paul R.; Raju, Robert N.; Lin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Phase I/II trial of gemcitabine plus doc

Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB

Phase II trial of weekly docetaxel and g

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

Phase II trial of weekly docetaxel and g

Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer

✍ Park, Se Hoon; Hong, Junshik; Kim, Young Saing; Kim, Yujin; Kyung, Sun Young; An 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 142 KB